Literature DB >> 9118960

1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling.

W Somers1, M Stahl, J S Seehra.   

Abstract

Interleukin 6 (IL-6) has many biological activities in vivo, and deregulation has been implicated in many disease processes. IL-6, a 185 amino acid polypeptide was refolded, purified and crystallized. The crystals diffracted to beyond 1.9 A and the structure was solved using single isomorphous replacement. The X-ray structure of IL-6 is composed of a four helix bundle linked by loops and an additional mini-helix. 157 out of 185 residues are well defined in the final structure, with 18 N-terminal and 8 A-B loop amino acids displaying no interpretable electron density. The three-dimensional structure has been used to construct a model of IL-6 interacting with the IL-6 receptor (alpha-chain) and gp130 (beta-chain) that gives new insight into the process of molecular recognition and signaling. Based on this model, we predict a fourth binding site on IL-6, a low affinity IL-6-IL-6 interaction, which may be necessary for the sequential assembly of a functional hexameric IL-6 receptor complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9118960      PMCID: PMC1169699          DOI: 10.1093/emboj/16.5.989

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  The receptor for ciliary neurotrophic factor.

Authors:  S Davis; T H Aldrich; D M Valenzuela; V V Wong; M E Furth; S P Squinto; G D Yancopoulos
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

2.  The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors.

Authors:  C P Hill; T D Osslund; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 3.  Haemopoietic receptors and helical cytokines.

Authors:  J F Bazan
Journal:  Immunol Today       Date:  1990-10

4.  Independence between binocular rivalry suppression duration and magnitude of suppression.

Authors:  R Fox; R Check
Journal:  J Exp Psychol       Date:  1972-05

5.  Involvement of the Arg179 in the active site of human IL-6.

Authors:  V Fontaine; R Savino; R Arcone; L de Wit; J P Brakenhoff; J Content; G Ciliberto
Journal:  Eur J Biochem       Date:  1993-02-01

6.  Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130.

Authors:  F D de Hon; E ten Boekel; J Herrman; C Clement; M Ehlers; T Taga; K Yasukawa; Y Ohsugi; T Kishimoto; S Rose-John
Journal:  Cytokine       Date:  1995-07       Impact factor: 3.861

7.  Analysis of human/mouse interleukin-6 hybrid proteins: both amino and carboxy termini of human interleukin-6 are required for in vitro receptor binding.

Authors:  M T Fiorillo; A Cabibbo; P Iacopetti; E Fattori; G Ciliberto
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

8.  Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.

Authors:  J Wijdenes; P C Heinrich; G Müller-Newen; C Roche; Z J Gu; C Clément; B Klein
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

9.  Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction.

Authors:  M Ehlers; J Grötzinger; F D deHon; J Müllberg; J P Brakenhoff; J Liu; A Wollmer; S Rose-John
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

10.  Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation.

Authors:  R Savino; A Lahm; A L Salvati; L Ciapponi; E Sporeno; S Altamura; G Paonessa; C Toniatti; G Ciliberto
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more
  55 in total

1.  A rhesus macaque rhadinovirus related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 encodes a functional homologue of interleukin-6.

Authors:  J A Kaleeba; E P Bergquam; S W Wong
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

3.  The crystal structure of human interferon beta at 2.2-A resolution.

Authors:  M Karpusas; M Nolte; C B Benton; W Meier; W N Lipscomb; S Goelz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Relationships between genetic polymorphisms in inflammation-related factor gene and the pathogenesis of nasopharyngeal cancer.

Authors:  Yan-Li Qu; Hong Yu; Yan-Zhi Chen; Yu-Xia Zhao; Guang-Jun Chen; Lu Bai; Dan Liu; Hong-Xin Su; He-Tong Wang
Journal:  Tumour Biol       Date:  2014-06-22

5.  Convergent evolution of IL-6 in two leporids (Oryctolagus and Pentalagus) originated an extended protein.

Authors:  Fabiana Neves; Joana Abrantes; Ana Pinheiro; Tereza Almeida; Paulo P Costa; Pedro J Esteves
Journal:  Immunogenetics       Date:  2014-07-16       Impact factor: 2.846

6.  Crystal structure of a cytokine-binding region of gp130.

Authors:  J Bravo; D Staunton; J K Heath; E Y Jones
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

7.  Limbal epithelial stem-microenvironmental alteration leads to pterygium development.

Authors:  Prosun Das; Arjun Gokani; Ketaki Bagchi; Gautam Bhaduri; Samaresh Chaudhuri; Sujata Law
Journal:  Mol Cell Biochem       Date:  2015-01-06       Impact factor: 3.396

8.  Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling.

Authors:  H Li; H Wang; J Nicholas
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 9.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

Review 10.  Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.

Authors:  Jean-Michel Dayer; Ernest Choy
Journal:  Rheumatology (Oxford)       Date:  2009-10-23       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.